share_log

Slammed 26% Applied UV, Inc. (NASDAQ:AUVI) Screens Well Here But There Might Be A Catch

Slammed 26% Applied UV, Inc. (NASDAQ:AUVI) Screens Well Here But There Might Be A Catch

26% 的應用紫外線公司(納斯達克股票代碼:AUVI)的屏幕在這裏大放異彩,但可能會有問題
Simply Wall St ·  04/02 07:09

To the annoyance of some shareholders, Applied UV, Inc. (NASDAQ:AUVI) shares are down a considerable 26% in the last month, which continues a horrid run for the company.    For any long-term shareholders, the last month ends a year to forget by locking in a 99% share price decline.  

令一些股東煩惱的是,Applied UV, Inc.(納斯達克股票代碼:AUVI)的股價在上個月下跌了26%,這延續了該公司的糟糕表現。對於任何長期股東來說,最後一個月的股價跌幅鎖定了99%的跌幅,從而結束了令人難忘的一年。

Since its price has dipped substantially, Applied UV may be sending buy signals at present with its price-to-sales (or "P/S") ratio of 0.1x, considering almost half of all companies in the Building industry in the United States have P/S ratios greater than 1.5x and even P/S higher than 4x aren't out of the ordinary.   However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.  

由於其價格大幅下跌,應用紫外目前可能正在發出買入信號,其市銷率(或 “市盈率”)爲0.1倍,因爲美國建築行業幾乎有一半的公司的市銷率超過1.5倍,即使市盈率高於4倍也並非不尋常。但是,市銷率低可能是有原因的,需要進一步調查以確定其是否合理。

NasdaqCM:AUVI Price to Sales Ratio vs Industry April 2nd 2024

納斯達克股票代碼:AUVI 與行業的股價銷售比率 2024 年 4 月 2 日

How Applied UV Has Been Performing

應用紫外線的表現如何

Applied UV certainly has been doing a great job lately as it's been growing its revenue at a really rapid pace.   One possibility is that the P/S ratio is low because investors think this strong revenue growth might actually underperform the broader industry in the near future.  If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.    

應用紫外線最近確實做得很好,因爲它的收入增長非常快。一種可能性是市銷率很低,因爲投資者認爲這種強勁的收入增長在不久的將來實際上可能低於整個行業。如果你喜歡這家公司,你希望情況並非如此,這樣你就有可能在它失寵的時候買入一些股票。

We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our free report on Applied UV's earnings, revenue and cash flow.  

我們沒有分析師的預測,但您可以查看我們關於Applied UV收益、收入和現金流的免費報告,了解最近的趨勢如何爲公司的未來做好準備。

Is There Any Revenue Growth Forecasted For Applied UV?  

預計應用紫外線的收入會增長嗎?

The only time you'd be truly comfortable seeing a P/S as low as Applied UV's is when the company's growth is on track to lag the industry.  

只有當公司的增長有望落後於行業時,你才能真正放心地看到像應用紫外線一樣低的市銷率。

Taking a look back first, we see that the company grew revenue by an impressive 99% last year.    The latest three year period has also seen an incredible overall rise in revenue, aided by its incredible short-term performance.  Therefore, it's fair to say the revenue growth recently has been superb for the company.  

首先回顧一下,我們發現該公司去年的收入增長了令人印象深刻的99%。得益於其令人難以置信的短期表現,最近三年的總體收入也實現了驚人的增長。因此,可以公平地說,該公司最近的收入增長非常好。

Comparing that recent medium-term revenue trajectory with the industry's one-year growth forecast of 6.9% shows it's noticeably more attractive.

將最近的中期收入軌跡與該行業6.9%的年度增長預測進行比較,可以看出該行業明顯更具吸引力。

With this in mind, we find it intriguing that Applied UV's P/S isn't as high compared to that of its industry peers.  Apparently some shareholders believe the recent performance has exceeded its limits and have been accepting significantly lower selling prices.  

考慮到這一點,我們發現有趣的是,Applied UV的市銷率與業內同行相比沒有那麼高。顯然,一些股東認爲最近的表現已經超過了極限,並且一直在接受大幅降低的銷售價格。

The Bottom Line On Applied UV's P/S

應用紫外線市銷率的底線

Applied UV's recently weak share price has pulled its P/S back below other Building companies.      We'd say the price-to-sales ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.

應用紫外光最近股價疲軟,使其市銷率回落至其他建築公司的下方。我們可以說,市銷比率的力量主要不是作爲一種估值工具,而是用來衡量當前的投資者情緒和未來預期。

Our examination of Applied UV revealed its three-year revenue trends aren't boosting its P/S anywhere near as much as we would have predicted, given they look better than current industry expectations.  When we see robust revenue growth that outpaces the industry, we presume that there are notable underlying risks to the company's future performance, which is exerting downward pressure on the P/S ratio.  It appears many are indeed anticipating revenue instability, because the persistence of these recent medium-term conditions would normally provide a boost to the share price.    

我們對Applied UV的審查顯示,其三年收入趨勢並沒有像我們預期的那樣提高市銷率,因爲這些趨勢看起來好於當前的行業預期。當我們看到強勁的收入增長超過行業時,我們認爲公司的未來業績存在明顯的潛在風險,這給市銷率帶來了下行壓力。看來許多人確實在預測收入不穩定,因爲近期這些中期狀況的持續下去通常會提振股價。

Plus, you should also learn about these   4 warning signs we've spotted with Applied UV.

另外,你還應該了解我們在應用紫外線中發現的這4個警告信號。

Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

當然,具有良好收益增長曆史的盈利公司通常是更安全的選擇。因此,您可能希望看到這些免費收集的市盈率合理且收益增長強勁的其他公司。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論